SEC Form 4 · accession 0001179110-15-011691
GILEAD SCIENCES, INC. · GILD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul Rutherford Carter
Officer — EVP Commercial Ops
Period of report
Jul 31, 2015
Accepted (ET)
Aug 4, 2015 · 5:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000882095
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 31, 2015 | M | 2,500 | $0.00 | A | 50,132 | D | |
| Common Stock | Jul 31, 2015 | F | 1,349 | $117.86 | D | 48,783 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF1,F2 | — | Jul 31, 2015 | M | 2,500 | A | — | — | Common Stock | 2,500 | 5,000 | D |
Explanation of responses
- F1Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock
- F2The restricted stock units vest 25% annually over a four year period after the date of grant.